Merus N.V.
Overview
Merus N.V. is a clinical-stage oncology company developing innovative multispecific antibody therapeutics. The company focuses on leveraging its proprietary Biclonics® technology platform to create therapies designed to address the complexities of cancer.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Merus N.V. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ace Pharmaceuticals B.V.
Netherlands
Amsterdam UMC
Netherlands
Amsterdam University Medical Centers
Netherlands
Amsterdam University Medical Centers, Location VUmc
Netherlands
Barentz International B.V.
Netherlands
Centrafarm Services B.V.
Netherlands
Maastricht University Medical Center+
Netherlands
Nutricia
Netherlands
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.